Skip to main content
Atrás
ADUS logo

Addus HomeCare Corporation

Calidad de datos: 100%
ADUS
NASDAQ Healthcare Medical - Care Facilities
$99.32
▲ $0.01 (0.01%)
Cap. Mercado: 1.85B
Rango del Día
$97.31 $100.25
Rango de 52 Semanas
$89.75 $124.44
Volumen
211,889
Promedio 50D / 200D
$106.92 / $111.86
Cierre Anterior
$99.31

Quick Summary

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (631 pares)

Métrica Acción Mediana del Sector
P/E 19.3 0.2
P/B 1.7 3.0
ROE % 9.3 3.6
Net Margin % 6.7 3.8
Rev Growth 5Y % 13.3 9.9
D/E 0.2 0.2

Precio Objetivo de Analistas

Hold
$128.67 +29.6%
Low: $112.00 High: $139.00
P/E Futuro
14.38
EPS Futuro
$6.91
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
1.52B

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2028 $8.08
$7.00 – $8.93
 1.66B 3
FY2027 $7.47
$7.29 – $7.58
 1.59B 7
FY2026 $6.91
$6.83 – $6.95
 1.52B 8

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-23 $1.72 $1.77 +2.9%
2025-11-03 $1.53 $1.56 +2.0%
2025-08-04 $1.45 $1.49 +2.8%
2025-05-05 $1.33 $1.42 +6.8%
2025-02-24 $1.35 $1.38 +2.2%
2024-11-04 $1.28 $1.30 +1.6%
2024-08-05 $1.21 $1.35 +11.6%
2024-05-06 $1.09 $1.21 +11.0%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Puntos Clave

Revenue grew 13.26% annually over 5 years — strong growth
Earnings grew 30.32% over the past year
Debt/Equity of 0.19 — conservative balance sheet
Negative free cash flow of 0.0
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 9.95%
Capital efficient — spends only 7.84% of revenue on capex

Crecimiento

Revenue Growth (5Y)
13.26%
Revenue (1Y)23.21%
Earnings (1Y)30.32%
FCF Growth (3Y)N/A

Calidad

Return on Equity
9.33%
ROIC8.03%
Net Margin6.74%
Op. Margin9.74%

Seguridad

Debt / Equity
0.19
Current Ratio1.80
Interest Coverage14.46

Valoración

P/E Ratio
19.31
Forward P/E14.38
P/B Ratio1.71
EV/EBITDA14.27
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 23.21% Revenue Growth (3Y) 15.92%
Earnings Growth (1Y) 30.32% Earnings Growth (3Y) 23.86%
Revenue Growth (5Y) 13.26% Earnings Growth (5Y) 20.74%
Profitability
Revenue (TTM) 1.42B Net Income (TTM) 95.91M
ROE 9.33% ROA 6.67%
Gross Margin 32.47% Operating Margin 9.74%
Net Margin 6.74% Free Cash Flow (TTM) 0.0
ROIC 8.03% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.19 Current Ratio 1.80
Interest Coverage 14.46
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 19.31 Forward P/E 14.38
P/B Ratio 1.71 P/S Ratio 1.30
PEG Ratio 1.04 Forward PEG N/A
EV/EBITDA 14.27 Fwd EV/EBITDA 13.16
Forward P/S 1.22 Fwd Earnings Yield 6.95%
FCF Yield 0.00%
Market Cap 1.85B Enterprise Value 1.98B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.42B 1.15B 1.06B 951.12M 864.50M
Net Income 95.91M 73.60M 62.52M 46.03M 45.13M
EPS (Diluted) 5.21 4.23 3.83 2.84 2.81
Gross Profit 461.87M 375.02M 339.88M 299.74M 269.85M
Operating Income 138.62M 102.69M 90.96M 68.74M 65.94M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.44B 1.41B 1.02B 937.99M 947.59M
Total Liabilities 352.01M 442.14M 317.73M 304.45M 373.24M
Shareholders' Equity 1.09B 970.49M 706.69M 633.54M 574.34M
Total Debt 208.62M 273.13M 175.18M 178.05M 263.55M
Cash & Equivalents 81.62M 98.91M 64.79M 79.96M 168.90M
Current Assets 269.49M 260.38M 200.00M 222.81M 324.34M
Current Liabilities 149.49M 155.87M 145.12M 131.15M 117.69M